Hanoi (VNA) ꦉ- Vietna🍃mese pharmaceutical companies are optimistic about the business prospects of the sector, as well as its potential in 2016-17.
This information was released in a survey alongside the top 10 most prestigious pharmaceutical companies in the country by the Ministry of Information and Communications and Vietnam Report Company (VNR) on October 25 in Hanoi.
Accordingly, more than 70 percent of businesses expect that the sector’s growth rate would be over 10 percent, the remaining participants expected that growth would be lower. There was no firm believing that growth would be worse than that of last year.
According to estimates from Business Monitor International (BMI), value of pharmaceutical consumption in Vietnam this year could maintain its high growth rate of 10.2 percent due to a young population and increasing incomes, together with rising attention to healthcare.
However, the value of domestically produced pharmaceuticals accounted for only 45 percent of the total, with the majority being popular, cheap, and simple medicines.
Most high value drugs were imported or distributed by foreign and joint venture companies.
It was because of that local firms would face difficulties in improving current products, enhancing investment and developing new products with limited capital, human resources and capacity.
Vietnamese pharmaceutical businesses have always been ready for challenges. Several local firms have sought ways to cooperate with foreign companies to take advantage of available markets and distribution channels instead of direct competition. The cooperation can help them attract capital, technologies and experience from big global groups.
The survey also found that in addition to internal factors, prestige had been considered one of the important factors affecting production and distribution. Around 86 percent of surveyed firms believed that prestige had been the most important factor, while 14 percent believed that it had relatively big impacts.
VNR said the survey on pharmacists and drug stores in Hanoi and HCM City showed that the medicine quality and treatment effectiveness should be given priority in building the prestige of pharmaceutical firms. The companies should undertake careful studies and production as the sector has a direct impact on people’s health. The marketing, sale, and distribution of healthcare should be supporting factors to improve prestige.
VNR said the average turnover of the top 10 most prestigious pharmaceutical companies in 2015 was over 2 trillion VND.
The result was based on three criteria of financial capacity performing on audited financial reports in the latest year, communication prestige and a survey on pharmaceutical firms and pharmacists on quality and distribution.
Most of the companies in the list have stable financial capacity, long-term experience and potential for growth as well as high quality products and distribution.-VNA
Former Deputy Minister of Health Doctor Le Van Truyen spoke with the Lao Dong (Labour) newspaper about why Vietnamese people are still hesitant to use domestically produced pharmaceuticals.
More and more domestic pharmaceutical firms have recently announced plans to expand their production as the market has shown signs of picking up in recent months, an English language news website reported.
Global healthcare company Abbott has announced that it had acquired Glomed Pharmaceutical Company Inc (Glomed), a leading Vietnamese drug manufacturer.
Local pharmaceutical companies should improve their competitive advantage before Vietnam signs the Trans-Pacific Partnership (TPP) Agreement in order to avoid losing their regional market share.
Vietnam now boasts a nationwide healthcare network with 1,665 hospitals, 384 of which are non-public, supported by local commune- and ward-level stations. At the end of 2024, hospital bed capacity reached 34 per 10,000 people, slightly above the global average.
The 56-year-old patient from Quang Tri province was discharged in stable condition as he no longer experienced shortness of breath and was able to walk, move around, and eat normally.
Associate Professor Dr. Nguyen Vu Trung, Director of the Pasteur Institute, said that under the MoU, the two sides committed to promoting diverse and practical collaborative activities, including joint conferences and workshops, exchanges of scholars, researchers and students, sharing academic materials, and the development of specific programmes and projects in scientific research, training, and epidemic prevention.
TytoCare, a leading Israeli telemedicine company based in Netanya, is willing to work with Vietnamese regulators, insurers, and healthcare providers to develop a sustainable digital health ecosystem.
The partnership is under the framework of a Memorandum of Understanding on the development and implementation of the National Action Plan on Breast Cancer and Cervical Cancer Prevention and Control, signed in Hanoi on July 22.
An estimated 7 million Vietnamese are currently living with diabetes, but about 50% remain undiagnosed, a dangerous gap that is fuelling serious, preventable complications and increasing the burden on the healthcare system.
In 2024, Vietnam achieved 99% coverage for the first dose of the diphtheria, tetanus and pertussis vaccine, up from 80% in 2023. Immunisation coverage in the country has not only rebounded to the high levels seen before the COVID-19 pandemic but has now surpassed the rates recorded in 2019.
Health authorities in HCM City have issued an urgent alert after six people died from dengue fever, amid a spike in infections driven by the onset of the rainy season.
During the peak months of July and August 2025, the National Institute of Haematology and Blood Transfusion (NIHBT) needs at least 90,000 units of blood to supply 180 hospitals in the northern region. However, despite continuous efforts, the reserve blood is still short of 30,000 units.
The Hanoi ceremony highlighted efforts to ensure all citizens, especially women and youth, can access accurate information and healthcare services to make informed reproductive choices.
After such a long time, the law has revealed many limitations, prompting the Ministry of Health (MoH) to gather opinions to amend the law to give more chances to thousands of patients every year.
Currently, cardiovascular specialists from the 108 Military Central Hospital are working alongside a team of Prof.Dr. Jan D. Schmitto, Deputy Director of MHH’s Department of Cardiac, Thoracic, Transplantation and Vascular Surgery on clinical trials for MCS devices, implanted in heart failure patients either as a bridge to transplantation or as permanent treatment.
The centre not only serves residents living on the island, but also receives tens of thousands of visitors every year, according to Assoc Prof Dr Tang Chi Thuong, Director of the HCM CIty Department of Health.
Not only does Vietnam attract international tourists with its landscapes, culture, and cuisine, but it is also gradually becoming a reliable destination for medical treatment, offering high-quality services at reasonable costs.
Over the past six months, 150 communal health stations in provinces including Ha Giang, Bac Kan, Lang Son, Lao Cai, Lai Chau, Yen Bai, Tay Ninh, Hau Giang, Ben Tre and Ca Mau have been equipped with information technology systems. In addition, 117 key provincial healthcare workers have received training, with thousands more expected to follow.
During the COVID-19 pandemic in 2020, the Ministry of Health swiftly launched a telemedicine programme, connecting more than 1,000 medical establishments nationwide. The model, which remains in operation, has benefited tens of thousands of patients, including foreign nationals.
After more than three weeks of intensive treatment, the patient's pneumonia improved, breathing stabilised, sedation was reduced, and the breathing tube was removed. He is now conscious, able to eat orally, and in recovery.
Illustrative image (Source: VNA)
